Carregant...
Lessons From LEADER – All-round Leadership
The large multinational, randomised, double-blind LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results - A Long Term Evaluation) trial recently reported the cardiovascular (CV) benefits achieved with liraglutide therapy in type 2 diabetes mellitus (T2DM). T...
Guardat en:
| Publicat a: | Eur Endocrinol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Touch Medical Media
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5813445/ https://ncbi.nlm.nih.gov/pubmed/29632591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17925/EE.2016.12.02.76 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|